Search

Search Constraints

You searched for: Author/Creator Hoshi, Senji

Search Results

1. A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I. (17th January 2017)

2. A prospective multicenter study of intermittent chemotherapy with docetaxel and prednisolone for castration-resistant prostate cancer. (28th June 2016)

3. Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study. (16th May 2020)

4. Bladder cancer metastasis producing beta‐human chorionic gonadotropin, squamous cell carcinoma antigen, granulocyte‐colony stimulating factor, and parathyroid hormone‐related protein. Issue 1 (14th December 2018)

5. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy. (11th September 2019)

6. Clinical response in metastatic castration‐resistant prostate cancer (mCRPC) cases treated with supra‐physiological doses of testosterone: Bipolar androgen therapy. Issue 2 (10th February 2022)

7. Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study. Issue 13 (23rd June 2022)

9. Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8. (18th January 2022)